Stay updated on Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial page.

Latest updates to the Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedPage revision updated from v3.6.3 to v3.6.4.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedRevision tag updated to v3.6.3, indicating a newer site build. This update does not modify the study details or other user-facing content.SummaryDifference0.0%

- Check36 days agoChange DetectedThe revision label was updated from v3.6.0 to v3.6.2, representing a minor software release for the page rather than a change to the study details.SummaryDifference0.0%

- Check50 days agoChange DetectedThe study page now shows 'No longer looking for participants,' indicating enrollment has closed and no new participants are being recruited. This reflects a recruitment status update to ensure the study record accurately represents current status.SummaryDifference0.2%

- Check58 days agoChange DetectedThe page revision updated from v3.5.4 to v3.5.5, indicating a newer build of the page.SummaryDifference0.0%

- Check79 days agoChange DetectedA new revision tag v3.5.4 was added and the previous revision v3.5.3 was removed.SummaryDifference0.0%

Stay in the know with updates to Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial page.